Recurrent Acute Tonsillitis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Recurrent Acute Tonsillitis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06606262

Tonsillectomy Versus Tonsillotomy in the Treatment of Recurrent Acute Tonsillitis

Background: recurrent acute tonsillitis (RT) is a frequent condition affecting teenagers and adults. Patients suffer from recurring throat symptoms, fever and i…

Denmark250 participantsStarted 2024-10-31

Treatment: Tonsillotomy, Tonsillectomy

All recent trials (4 shown)

Active — Not RecruitingNot Applicable

NCT03654742

Intracapsular Tonsillectomy in Adults

Comparing the classical extracapsular tonsillectomy (TE) performed with electrosurgery to intracapsular approaches (SIPT) by coblation or microdebrider. The pat…

Finland167 participantsStarted 2019-09-27

Treatment: tonsillectomy

TerminatedPhase 2

NCT01498796

KITS Study -Ketorolac In Tonsillectomy Surgery: a Double Blinded, Randomized Clinical Trial

Our group wishes to test the novel hypothesis that intraoperative use of ketorolac in pediatric patients undergoing tonsillectomy reduces post-operative nausea…

Canada121 participantsStarted 2009-09

Treatment: Ketorolac, Normal Saline

Recurrent Acute Tonsillitis

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Tonsillectomy Versus Tonsillotomy in the Treatment of Recurrent Acute Tonsillitis

All recent trials (4 shown)

Intracapsular Tonsillectomy in Adults

KITS Study -Ketorolac In Tonsillectomy Surgery: a Double Blinded, Randomized Clinical Trial

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Tonsillectomy Versus Tonsillotomy in the Treatment of Recurrent Acute Tonsillitis

All recent trials (4 shown)

Intracapsular Tonsillectomy in Adults

KITS Study -Ketorolac In Tonsillectomy Surgery: a Double Blinded, Randomized Clinical Trial

CLEARI (Clinical Efficacy Assessment on Recurrent Upper-Respiratory Tract Infections) Study